Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1689548 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $295.81Day −6.33%Mkt cap $8.2B1Y +431.6%Off 52W high −19.3%Vol (1Y) 201.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,359 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest13.5% of sh out |
| Days to cover9.2d |
| 13F net flow (QoQ)+9.41% |
| Top-10 13F concentration57.2% |
| Next report (est.)2026-08-07 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$326.5M |
| ROE−45.8% |
| ROIC−68.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+0.4% |
| 1Y+431.6% |
| 3Y+1922.4% |
| 5Y+25.4% |
| Since incept. (ann.)−15.9% |
Total return through 2026-07-28 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)201.6% |
| Ann. volatility (3Y)135.5% |
| Sharpe (1Y)1.40 |
| Sharpe (3Y)1.24 |
| Max drawdown (1Y)−33.4% |
| Max drawdown (3Y)−68.6% |
| Beta (3Y vs SPY)1.34 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 3.5M | $1.1B | 12.41% | +6.8% |
| Orbis Allan Gray Ltd | 2.5M | $797M | 8.87% | +97.0% |
| BlackRock, Inc. | 2.3M | $749M | 8.34% | +11.9% |
| FMR LLC | 2.2M | $696M | 7.75% | +59.0% |
| PERCEPTIVE ADVISORS LLC | 2.0M | $656M | 7.30% | +2.0% |
| BAKER BROS. ADVISORS LP | 1.8M | $565M | 6.29% | +55.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $394M | 4.38% | new |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 963,351 | $310M | 3.46% | +6.6% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 114.2% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 3,775,673 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$3.20 | — | — | — |
| 2025-12-31 | 2026-02-19 | — | — | $0 | −100.0% |
| 2025-09-30 | 2025-11-05 | −$3.36 | — | $0 | −100.0% |
| 2025-06-30 | 2025-08-04 | −$3.31 | — | $0 | −100.0% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-07 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
